Sol-Gel Technologies Ltd. Company Profile
NASDAQ: SLGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Sol-Gel Technologies at a glance
Sol-Gel Technologies Ltd. (NASDAQ: SLGL) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Ness Ziona, Israel. Sol-Gel Technologies is led by Mr. Moshe Arkin and employs about 28 people. The company's shares have traded publicly since 2018.
At a market capitalization of $180.6 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001684693, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Sol-Gel Technologies do?
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- Sol-Gel Technologies Ltd.
- Ticker
- NASDAQ: SLGL
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Moshe Arkin
- Employees
- 28
- Headquarters
- 7 Golda Meir Street, Ness Ziona, Israel
- Phone
- 972 8 931 3433
- Website
- sol-gel.com
- IPO year
- 2018
- Market cap
- $180.63M
- SEC CIK
- 0001684693
Companies similar to Sol-Gel Technologies
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| WHWKWhitehawk Therapeutics Inc. | 3.07 | -1.60% | $181.16M | vs SLGL |
| ADCTADC Therapeutics SA | 1.28 | -1.54% | $180.05M | vs SLGL |
| NATRNature's Sunshine Products Inc. | 10.18 | +0.10% | $176.41M | vs SLGL |
| VOGXVogenx Inc | 11.87 | -7.30% | $176.33M | vs SLGL |
| RNACCartesian Therapeutics Inc. | 6.14 | +4.24% | $187.29M | vs SLGL |
| SIGASIGA Technologies Inc. | 2.40 | -9.43% | $172.45M | vs SLGL |
| TRDAEntrada Therapeutics Inc. | 4.35 | -6.25% | $170.30M | vs SLGL |
| ANTXAN2 Therapeutics Inc. | 5.08 | -2.68% | $192.75M | vs SLGL |